E-LIB Suche - Ergebnisse für: Campani, C.

1

Management of portal hypertension in patients receiving ate..:

Tovoli, F. ; Franceschini, E. ; Vivaldi, C....
Digestive and Liver Disease. 56 (2024) - p. S87 , 2024

Link: https://doi.org/10.1016/..

2

Can AtezoBev be a safe and effective option for treating he..:

Stella, L. ; Pallozzi, M. ; Cerrito, L....
Digestive and Liver Disease. 56 (2024) - p. S78 , 2024

Link: https://doi.org/10.1016/..

3

Aetiology of hepatocellular carcinoma and response to immun..:

Tovoli, F. ; Chen, R. ; Vivaldi, C....
Digestive and Liver Disease. 56 (2024) - p. S92-S93 , 2024

Link: https://doi.org/10.1016/..

4

End-procedural complete haemodynamic response may not be es..:

Roccarina, D. ; Rosi, M. ; Saltini, D....
Digestive and Liver Disease. 56 (2024) - p. S5-S6 , 2024

Link: https://doi.org/10.1016/..

5

Role of ganglioside GD2 in the stem-like compartment of int..:

Mannini, A. ; Pastore, M. ; Correnti, M....
Digestive and Liver Disease. 56 (2024) - p. S95-S96 , 2024

Link: https://doi.org/10.1016/..

6

Efficacy and safety of atezolizumab/bevacizumab for hepatoc..:

Tovoli, F. ; Vivaldi, C. ; Federico, P....
Digestive and Liver Disease. 56 (2024) - p. S85-S86 , 2024

Link: https://doi.org/10.1016/..

7

Sorafenib as a second-line treatment after failure of atezo..:

Tovoli, F. ; Boe, M. ; Vivaldi, C....
Digestive and Liver Disease. 56 (2024) - p. S79 , 2024

Link: https://doi.org/10.1016/..

8

The impact of etiology on patterns of progression of advanc..:

Stefanini, B. ; Piscaglia, F. ; Dalbeni, A....
Digestive and Liver Disease. 56 (2024) - p. S17 , 2024

Link: https://doi.org/10.1016/..

9

Hepatocyte depletion of ERK5 impairs the response to lipoto..:

Menconi, A. ; Di Maira, G. ; Lori, G....
Digestive and Liver Disease. 55 (2023) - p. S49 , 2023

Link: https://doi.org/10.1016/..

10

Dynamic evolution of circulating tumor DNA in patients with..:

Campani, C. ; Imbeaud, S. ; Ziol, M....
Digestive and Liver Disease. 55 (2023) - p. S213-S214 , 2023

Link: https://doi.org/10.1016/..

11

Lack of substantial improvements in the landscape of alcoho..:

Reggidori, N. ; Bucci, L. ; Santi, V....
Digestive and Liver Disease. 55 (2023) - p. S16-S17 , 2023

Link: https://doi.org/10.1016/..

12

MerTK-expressing macrophages promote the malignant features..:

Pastore, M. ; Geyik, Ö. Gönül ; Andersen, J....
Digestive and Liver Disease. 55 (2023) - p. S226 , 2023

Link: https://doi.org/10.1016/..

13

Clinical impact of relative dose intensity of cabozantinib ..:

Tovoli, F. ; Dadduzio, V. ; De Lorenzo, S....
Digestive and Liver Disease. 55 (2023) - p. S224-S225 , 2023

Link: https://doi.org/10.1016/..

14

Preoperative predictors of recurrence beyond Milan criteria..:

Pelizzaro, F. ; Trevisani, F. ; Vitale, A....
Digestive and Liver Disease. 55 (2023) - p. S52-S53 , 2023

Link: https://doi.org/10.1016/..

15

Liver function is a predictor of survival in patients with ..:

Campani, C. ; Bucci, L. ; Adotti, V....
Digestive and Liver Disease. 55 (2023) - p. S74-S75 , 2023

Link: https://doi.org/10.1016/..